Advancing Whole-Organism Screening for Chemical Modifiers of the Brain
推进大脑化学修饰物的整体有机体筛选
基本信息
- 批准号:8606524
- 负责人:
- 金额:$ 19.22万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2013
- 资助国家:美国
- 起止时间:2013-02-01 至 2016-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffectAlgorithmsAnimal ModelAutomationBiologicalBiological AssayBiologyBlood - brain barrier anatomyBrainCellsCentral Nervous System DiseasesChemical ModifierChemicalsComb animal structureComplexDevelopmentDiseaseEmbryoEmploymentFishesFoundationsGoalsGrantHeadHealthHourHumanImageImage AnalysisImaging technologyIndividualInjection of therapeutic agentLarvaLeadLightingLiteratureMaintenanceMechanicsMethodsMicrofluidicsMicroscopeMicroscopyNatural regenerationNatureNerve DegenerationNervous system structureNeuraxisNeurodegenerative DisordersOperative Surgical ProceduresOrganismOutcomes ResearchParkinson DiseasePharmaceutical PreparationsPhenotypePositioning AttributeProcessProteinsReportingResearchResolutionRoboticsSamplingScanningSpeedStagingSystemTechniquesTechnologyTestingTherapeuticThickThree-Dimensional ImagingTimeTreatment outcomeWhole OrganismZebrafishbasedesigndopaminergic neurondrug discoveryfluorescence imaginghigh throughput screeningimprovedin vitro Assayin vivomacromoleculemeetingsnervous system developmentnoveloperationpreventpublic health relevanceresearch studyscreeningsmall molecule
项目摘要
DESCRIPTION (provided by applicant): The suitability for large-scale screening and the transparent nature during embryonic and larval stages make zebrafish an attractive system for small molecule screening in an intact organism, with aims both to identify therapeutic compounds and to understand biological mechanisms. DA neurons degenerate in human Parkinson's disease (PD), a devastating neurodegenerative disorder for which there is currently no cure. Zebrafish, as a prominent vertebrate model organism with the ability to produce a large number of transparent embryos and larvae, is ideally suited for discovering small molecules that can regulate the development, maintenance, or regeneration of DA neurons. However, key limitations with whole organism-based chemical screening is low throughput and low resolution. In this proposal, we will advance whole organism screening by developing and integrating fast speed high-resolution whole-organism imaging with an improved microfluidics- based technology, using the DA neuron assay that we have already established. If successful, this platform will revolutionize the whole-organism screening capability and lead to novel small molecule compounds that can modify CNS development and function and provide leads for potential treatment of PD.
描述(由申请人提供):斑马鱼在胚胎和幼虫阶段的大规模筛选和透明性质的适用性使其成为在完整生物体中进行小分子筛选的有吸引力的系统,目的是鉴定治疗化合物并了解生物学机制。DA神经元在人类帕金森病(PD)中退化,帕金森病是一种目前无法治愈的破坏性神经退行性疾病。斑马鱼作为一种能够产生大量透明胚胎和幼虫的脊椎动物模式生物,非常适合发现可以调节DA神经元发育、维持或再生的小分子。然而,基于整个生物体的化学筛选的关键限制是低通量和低分辨率。在该提案中,我们将通过使用我们已经建立的DA神经元测定,开发并整合快速高分辨率全生物体成像与改进的基于微流体的技术,来推进全生物体筛选。如果成功,该平台将彻底改变整个生物体的筛选能力,并导致新的小分子化合物,可以改变CNS的发育和功能,并为PD的潜在治疗提供线索。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Adam R. Abate其他文献
FIND-seq: high-throughput nucleic acid cytometry for rare single-cell transcriptomics
FIND-seq:用于罕见单细胞转录组学的高通量核酸细胞计数术
- DOI:
10.1038/s41596-024-01021-y - 发表时间:
2024-07-22 - 期刊:
- 影响因子:16.000
- 作者:
Seung Won Shin;Prakriti Mudvari;Shravan Thaploo;Michael A. Wheeler;Daniel C. Douek;Francisco J. Quintana;Eli A. Boritz;Adam R. Abate;Iain C. Clark - 通讯作者:
Iain C. Clark
Adam R. Abate的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Adam R. Abate', 18)}}的其他基金
Next Generation Infectious Disease Diagnostics: Microfluidic-Free Gigapixel PCR with Self-Assembled Partitioning
下一代传染病诊断:具有自组装分区的无微流控千兆像素 PCR
- 批准号:
10682295 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
Sorting and Sequencing Latent Reservoirs in HIV+ Opioid Users
HIV阿片类药物使用者中潜在储库的分类和测序
- 批准号:
10789790 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
A non-invasive metabolic sensor for improving success in IVF
用于提高 IVF 成功率的非侵入性代谢传感器
- 批准号:
10741730 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
Identification of regulatory mechanisms operating in rare pathogenic astrocyte subsets in multiple sclerosis with a novel genomic technology
利用新型基因组技术鉴定多发性硬化症中罕见致病性星形胶质细胞亚群的调节机制
- 批准号:
10737509 - 财政年份:2023
- 资助金额:
$ 19.22万 - 项目类别:
A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution
用于超高通量生物催化剂进化的通用液滴微流控平台
- 批准号:
10547670 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
A universal droplet microfluidic platform for ultrahigh-throughput biocatalyst evolution
用于超高通量生物催化剂进化的通用液滴微流控平台
- 批准号:
10705725 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Ultrahigh Throughput Microscale Mass Spectrometry for Pharmaceutical Prenylation Enzyme Engineering
用于药物异戊二烯化酶工程的超高通量微型质谱分析
- 批准号:
10325565 - 财政年份:2021
- 资助金额:
$ 19.22万 - 项目类别:
Multi-omic dissection of the transcriptional, epigenetic, and proteomic signatures of cells infected with latent HIV
对潜伏 HIV 感染细胞的转录、表观遗传和蛋白质组学特征进行多组学分析
- 批准号:
10447107 - 财政年份:2020
- 资助金额:
$ 19.22万 - 项目类别:
A platform for engineering peptide ligase for building next generation peptide therapeutics.
用于构建下一代肽疗法的肽连接酶工程平台。
- 批准号:
9908228 - 财政年份:2020
- 资助金额:
$ 19.22万 - 项目类别:
Multi-omic dissection of the transcriptional, epigenetic, and proteomic signatures of cells infected with latent HIV
对潜伏 HIV 感染细胞的转录、表观遗传和蛋白质组学特征进行多组学分析
- 批准号:
10197751 - 财政年份:2020
- 资助金额:
$ 19.22万 - 项目类别:
相似海外基金
CAREER: Blessing of Nonconvexity in Machine Learning - Landscape Analysis and Efficient Algorithms
职业:机器学习中非凸性的祝福 - 景观分析和高效算法
- 批准号:
2337776 - 财政年份:2024
- 资助金额:
$ 19.22万 - 项目类别:
Continuing Grant
CAREER: From Dynamic Algorithms to Fast Optimization and Back
职业:从动态算法到快速优化并返回
- 批准号:
2338816 - 财政年份:2024
- 资助金额:
$ 19.22万 - 项目类别:
Continuing Grant
CAREER: Structured Minimax Optimization: Theory, Algorithms, and Applications in Robust Learning
职业:结构化极小极大优化:稳健学习中的理论、算法和应用
- 批准号:
2338846 - 财政年份:2024
- 资助金额:
$ 19.22万 - 项目类别:
Continuing Grant
CRII: SaTC: Reliable Hardware Architectures Against Side-Channel Attacks for Post-Quantum Cryptographic Algorithms
CRII:SaTC:针对后量子密码算法的侧通道攻击的可靠硬件架构
- 批准号:
2348261 - 财政年份:2024
- 资助金额:
$ 19.22万 - 项目类别:
Standard Grant
CRII: AF: The Impact of Knowledge on the Performance of Distributed Algorithms
CRII:AF:知识对分布式算法性能的影响
- 批准号:
2348346 - 财政年份:2024
- 资助金额:
$ 19.22万 - 项目类别:
Standard Grant
CRII: CSR: From Bloom Filters to Noise Reduction Streaming Algorithms
CRII:CSR:从布隆过滤器到降噪流算法
- 批准号:
2348457 - 财政年份:2024
- 资助金额:
$ 19.22万 - 项目类别:
Standard Grant
EAGER: Search-Accelerated Markov Chain Monte Carlo Algorithms for Bayesian Neural Networks and Trillion-Dimensional Problems
EAGER:贝叶斯神经网络和万亿维问题的搜索加速马尔可夫链蒙特卡罗算法
- 批准号:
2404989 - 财政年份:2024
- 资助金额:
$ 19.22万 - 项目类别:
Standard Grant
CAREER: Efficient Algorithms for Modern Computer Architecture
职业:现代计算机架构的高效算法
- 批准号:
2339310 - 财政年份:2024
- 资助金额:
$ 19.22万 - 项目类别:
Continuing Grant
CAREER: Improving Real-world Performance of AI Biosignal Algorithms
职业:提高人工智能生物信号算法的实际性能
- 批准号:
2339669 - 财政年份:2024
- 资助金额:
$ 19.22万 - 项目类别:
Continuing Grant
DMS-EPSRC: Asymptotic Analysis of Online Training Algorithms in Machine Learning: Recurrent, Graphical, and Deep Neural Networks
DMS-EPSRC:机器学习中在线训练算法的渐近分析:循环、图形和深度神经网络
- 批准号:
EP/Y029089/1 - 财政年份:2024
- 资助金额:
$ 19.22万 - 项目类别:
Research Grant